New scan aims to spot Cancer's retreat sooner
NCT ID NCT04273555
Summary
This study aimed to see if a new combination of PET and MRI scans could detect how well treatment is working in patients with advanced HER2-positive breast cancer earlier than current methods. The plan was to scan patients up to three times during their treatment to look for changes in the cancer. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
Conditions
Explore the condition pages connected to this study.